Privia Health
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the prim...
Latest News
6 days ago · zacks.com
3 Reasons Why Growth Investors Shouldn't Overlook Privia Health (PRVA)Privia Health (PRVA) could produce exceptional returns because of its solid growth attributes.
6 days ago · zacks.com
How Much Upside is Left in Privia Health (PRVA)? Wall Street Analysts Think 29.22%The average of price targets set by Wall Street analysts indicates a potential upside of 29.2% in Privia Health (PRVA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
11 days ago · marketbeat.com
Privia Health Group Q3 Earnings Call HighlightsPrivia Health Group NASDAQ: PRVA raised its 2026 financial outlook after reporting growth in providers, patient attribution and adjusted earnings through the first nine months of the year. The company also announced a $36 million acquisition that will expand its Medicare value-based care footprint in 2027.
12 days ago · seekingalpha.com
Privia Health Group, Inc. (PRVA) Q3 2026 Earnings Call TranscriptPrivia Health Group, Inc. (PRVA) Q3 2026 Earnings Call Transcript
12 days ago · zacks.com
Privia Health (PRVA) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesThe headline numbers for Privia Health (PRVA) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
12 days ago · zacks.com
Privia Health (PRVA) Q3 Earnings and Revenues Top EstimatesPrivia Health (PRVA) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.05 per share a year ago.
12 days ago · globenewswire.com
Privia Health Reports Strong Third Quarter and Year-to-Date 2026 ResultsPrivia Health Reports Strong Q3 and YTD 2026 Results - Adjusted EBITDA of $114.7M, +21.9% from YTD'25 – FY'26 Guidance Raised for All Key Financial Metrics
15 days ago · globenewswire.com
Privia Health Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP BusinessARLINGTON, Va., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the acquisition of American Choice Healthcare MSSP, LLC (ACH), a wholly-owned subsidiary of Cano Health.
26 days ago · seekingalpha.com
Privia Health Group: Operating Leverage Could Lead To Share Price UpsidePrivia Health Group is rated BUY, supported by strong operating leverage and expanding value-based care, positioning for earnings upside. PRVA trades at a 48% discount to its five-year average forward EV/EBITDA, with 24% forward EBITDA growth, outpacing peers. 2Q26 results showed 15% care margin growth, 29% adjusted EBITDA growth, and robust provider and patient expansion, highlighting operating efficiency.
1 month ago · globenewswire.com
Privia Health to Report Third Quarter 2026 Results on Thursday, November 5ARLINGTON, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its third-quarter and nine-month periods ended September 30, 2026 before market open on Thursday, November 5, 2026.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove PRVA